Zhang Hanzhao, Zhang Jingping
Infectious Diseases Department, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Future Microbiol. 2025 Mar;20(4):333-343. doi: 10.1080/17460913.2025.2457858. Epub 2025 Jan 27.
() is an opportunistic pathogenic fungus that often causes severe infections in immunosuppressed patients. Among species, is the most pathogenic and lethal species. Current research faces challenges related to unknown pathogenic mechanisms, complex resistance mechanisms, insufficiently rapid and accurate diagnostic methods, and insufficient research on susceptibility to infection. These issues need to be explored in depth. This review summarizes research progress on the origin and classification of , its virulence factors and pathogenic mechanisms, epidemiological characteristics, infection modes, diagnostic methods, drug treatment options, and drug resistance mechanisms. Traditional culture combined with molecular biology techniques, such as polymerase chain reaction and gene sequencing, has improved the accuracy and speed of detection. Treatment relies mainly on azole antifungal drugs and amphotericin B; however, patients are facing the problem of drug resistance. New techniques, such as gene knockout and gene sequencing, have identified resistance mechanisms, thus supporting the development of novel antifungal drugs. In summary, an in-depth study of will aid in developing more effective diagnostic and therapeutic methods and improve patient prognosis.
()是一种机会致病性真菌,常导致免疫抑制患者发生严重感染。在该属物种中,()是致病性最强且致死性最高的物种。当前的研究面临诸多挑战,包括致病机制不明、耐药机制复杂、诊断方法不够快速准确以及对感染易感性的研究不足等。这些问题需要深入探讨。本综述总结了关于()的起源与分类、毒力因子与致病机制、流行病学特征、感染模式、诊断方法、药物治疗选择以及耐药机制的研究进展。传统培养结合聚合酶链反应和基因测序等分子生物学技术,提高了检测的准确性和速度。治疗主要依赖唑类抗真菌药物和两性霉素B;然而,患者正面临耐药问题。基因敲除和基因测序等新技术已确定了耐药机制,从而为新型抗真菌药物的研发提供了支持。总之,对()进行深入研究将有助于开发更有效的诊断和治疗方法,并改善患者预后。